Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Procter & Gamble Company (PG), Johnson & Johnson (JNJ): Three Solid Companies to Purchase in Shaky Markets

Page 1 of 2

The broader indices have gone through some choppy seas lately. After seven months of rising, the S&P 500 has fallen from 1650 to 1550 only to rally quickly back to the 1600 level.  The recent market volatility is most likely due to macro concerns that the Federal Reserve’s quantitative easing program will be gradually discontinued. Interest rates and mortgage rates are slowly creeping higher and higher, inspiring a risk-off sell off. To make matters worse, China’s economy is rapidly slowing as it has to deal with trouble in its shadow bank system and bad loans made by its major banks.

What should an investor do in these extremely volatile times? A timeless strategy is to buy stable companies that beat the market in bad times, and keep up with the market in good times. These companies may not be as flashy as Google or Apple, but they consistently raise their dividends year after year and have great ROI’s.

The Procter & Gamble Company (NYSE:PG)

Procter & Gamble

The Procter & Gamble Company (NYSE:PG) is a diversified consumer products company. It sells everything from toothpaste to batteries and razor blades. Famous hedge fund manager Bill Ackman owns a significant portion of this stock, and recently successfully agitated for a new change of CEO. Considering that Bill Ackman did the same thing for Canadian Pacific railroad, and Canadian Pacific’s stock price subsequently doubled the next year, the Ackman touch with P&G might be able work some wonders. Bill Ackman believes that the new CEO will be able to reduce Procter & Gamble’s bloated overhead cost structure, raise organic revenue growth rate from the present 3% to 5%, and subsequently increase P&G’s earnings power from the present $4 a share to $6 a share in fiscal year 2016. With a payout ratio of only 48%, The Procter & Gamble Company (NYSE:PG)’s dividend should follow earnings and increase meaningfully as well.

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) is a diversified healthcare company. It makes everything from Tylenol and Band-Aid to heart stents. The company has a large pipeline of new healthcare products and should benefit as baby boomers age. Analysts have an average price target of $89 or around 5% above current levels. In terms of finances, this company has paid a dividend every year since 1944 and has increased its dividend for 51 straight years.  Wall Street analysts are projecting that Johnson & Johnson’s EPS will grow on average of 6.28% a year for the next 5 years. With a payout ratio of only 65%, Johnson and Johnson (NYSE:JNJ)’s 3.07% yield should follow course.


McDonald’s Corporation (NYSE:MCDis the world’s preeminent fast food chain. It counts Warren Buffett as a significant investor. McDonald’s outperformed the index in 2008 rising 7% when the S&P fell 38% and should do well in any type of correction. With China and India still growing and incomes rising significantly, McDonald’s has the potential to maintain its steady pace of price appreciation.

With about 2000 restaurants in China and 250 in India, McDonald’s Corporation (NYSE:MCD) has plenty of room to grow.  McDonald’s is projected to open more than 200 this year alone in China. The company also has shown the potential to innovate. It was one of the very first investors of Red Box and also held a significant stake in Chipotle. With a projected next 5 year EPS growth of 8.6%, and a payout ratio of only 54%, McDonald’s 3.6% dividend looks stable and likely to increase.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!